Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > NASDAQ and required Rollback
View:
Post by Iotamaniac1969 on Aug 14, 2021 9:52pm

NASDAQ and required Rollback

Folks,

it's garbage what these previous posters are stating.   I fully expect XRX to keep trucking north before the Nasdaq listing inside of 60 days.   The consolidation will happen simultaneously with the uplist.   I'm expecting news on several fronts inside this timeframe to keep driving value.   Do you know that the most recent Eresearch report comparables for Pre-Revenue Phase 3 companies garner and average Market Cap of 600m USD on the Nasdaq.    Google XORTX Eresearch and see for your self.   At most there will be a 10-1 rollback to get us around 7$ listing price.    This will keep rising.    TICO
Comment by 13X2413 on Aug 14, 2021 10:59pm
Thanks for providing some positive input. Hope you're right. Something just didn't seem right, I may have been a bit too panicky   Signed, Previous Garbage Poster. 
Comment by SSeahawk053 on Aug 15, 2021 1:46am
This may be so, but come on...announcing or sneaking it in on a Friday press release. No explanation on why the consolidation ratio as high as 45-1 would be acceptable to Allen and management?  I wouldn't call that good or even fair business practices. Sneaky is more like it, and hope people don't ask questions and vote in favor of what management recommends?  Management was also ...more  
Comment by KOkidneydisease on Aug 16, 2021 8:19am
Where did you get 45-1 from. AND you are making good points, I'd sell if I was you. Let me know when you do please.
Comment by Richmond on Aug 15, 2021 12:56pm
You must be a Management Guy who doesn't like Shareholders/ Investors plight on ROLLBACK 45:1 or 5:1 or even 2:1....Just not a GOOD BUSINESS PRACTICE!!!!. ROLLBACKS ARE BIG TIME FAILURES!!.....JUST RELEASE SOME VALUE FILLED NRs znd Share Price will fly....STOP ROLLBACK. REPORT TO SEC!!!!
Comment by ACTIONK on Aug 15, 2021 1:08pm
The nice thing about being a shareholders is that you can sell your shares. If you don't like the leadership and what they are executing - SELL YOUR SHARES and move on.  Moving on to being positive.
Comment by NLMoose on Aug 15, 2021 3:11pm
Or even better, say no to their plans for trying to emulate Kraken Robotics and FSD Pharma in consolidating their shares.
Comment by Richmond on Aug 15, 2021 12:51pm
That's BS...10:1 ROLLBACK? Why? Shouldn't be any ROLLBACK allowed from 130M. Shares o/s. Just release the value filled NRs and the SP should ruse on its own strength to $5++++ . EOM
Comment by KOkidneydisease on Aug 16, 2021 8:14am
Nervous Nellies are more likely sophisticated traders trying to get your shares. This is ALL GOOD FOLKS!!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities